Association between +61G polymorphism of the EGF gene and glioma risk in different ethnicities: A meta-analysis

Tohoku Journal of Experimental Medicine

Volumn 222, Issue 4, 2010, Pages 229-235

  Tan, Dianhui ^a   Xu, Jincheng ^a   Li, Yong ^a   Lai, Runlong ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

EGF; Glioma; Meta analysis; Polymorphism; Risk

Indexed keywords

EPIDERMAL GROWTH FACTOR; GLYCINE;

ALLELE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; ETHNIC DIFFERENCE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION; GLIOMA; HUMAN; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; DATABASES, GENETIC; EPIDERMAL GROWTH FACTOR; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION TO DISEASE; GLIOMA; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS;

EID: 78650037587     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.222.229     Document Type: Article

References (28)

1. Bhowmick, D.A., Zhuang, Z., Wait, S.D. & Weil, R.J. (2004) A functional polymorphism in the EGF gene is found with increased frequency in glioblastoma multiforme patients and is associated with more aggressive disease. Cancer Res., 64, 1220-1223.
2. Chen, P., Wiencke, J., Aldape, K., Kesler-Diaz, A., Miike, R., Kelsey, K., Lee, M., Liu, J. & Wrensch, M. (2000) Association of an ERCC1 polymorphism with adult-onset glioma. Cancer Epidemiol. Biomarkers Prev., 9, 843-847.
3. Costa, B.M., Ferreira, P., Costa, S., Canedo, P., Oliveira, P., Silva, A., Pardal, F., Suriano, G., Machado, J.C., Lopes, J.M. & Reis, R.M. (2007) Association between functional EGF+61 polymorphism and glioma risk. Clin. Cancer Res., 13, 2621-2626.
4. DerSimonian, R. & Laird, N. (1986) Meta-analysis in clinical trials. Control. Clin. Trials, 7, 177-188.
5. Egger, M., Davey Smith, G., Schneider, M. & Minder, C. (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-634.
6. Ekstrand, A.J., James, C.D., Cavenee, W.K., Seliger, B., Pettersson, R.F. & Collins, V.P. (1991) Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo. Cancer Res., 51, 2164-2172.
7. Feldkamp, M.M., Lau, N. & Guha, A. (1997) Signal transduction pathways and their relevance in human astrocytomas. J. Neurooncol., 35, 223-248.
8. Higgins, J.P., Thompson, S.G., Deeks, J.J. & Altman, D.G. (2003) Measuring inconsistency in meta-analyses. BMJ, 327, 557-560.
9. Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J. & Thun, M.J. (2009) Cancer statistics, 2009. CA Cancer J. Clin., 59, 225-249.
10. Jorissen, R.N., Walker, F., Pouliot, N., Garrett, T.P., Ward, C.W. & Burgess, A.W. (2003) Epidermal growth factor receptor: mechanisms of activation and signalling. Exp. Cell Res., 284, 31-53.
11. Limaye, P.B., Bowen, W.C., Orr, A.V., Luo, J., Tseng, G.C. & Michalopoulos, G.K. (2008) Mechanisms of hepatocyte growth factor-mediated and epidermal growth factor-mediated signaling in transdifferentiation of rat hepatocytes to biliary epithelium. Hepatology, 47, 1702-1713.
12. Liu, X., Li, L., Chen, X., Wang, X., Mu, L., Li, Y., Xu, Q., Xie, Q. & Lu, F. (2009) No association between EGF +61 A/G polymorphism and increased risk of glioma. Int. J. Biol. Markers, 24, 77-82.
13. Louis, D.N., Ohgaki, H., Wiestler, O.D., Cavenee, W.K., Burger, P.C., Jouvet, A., Scheithauer, B.W. & Kleihues, P. (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol., 114, 97-109.
14. Mantel, N. & Haenszel, W. (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst., 22, 719-748.
15. Normanno, N., De Luca, A., Bianco, C., Strizzi, L., Mancino, M., Maiello, M.R., Carotenuto, A., De Feo, G., Caponigro, F. & Salomon, D.S. (2006) Epidermal growth factor receptor (EGFR) signaling in cancer. Gene, 366, 2-16.
16. Ohgaki, H. & Kleihues, P. (2005) Epidemiology and etiology of gliomas. Acta Neuropathol., 109, 93-108.
17. Pinto, G.R., Yoshioka, F.K., Clara, C.A., Santos, M.J., Almeida, J.R., Burbano, R.R., Rey, J.A. & Casartelli, C. (2009) Association study of an epidermal growth factor gene functional polymorphism with the risk and prognosis of gliomas in Brazil. Int. J. Biol. Markers, 24, 277-281.
18. Salomon, D.S., Brandt, R., Ciardiello, F. & Normanno, N. (1995) Epidermal growth factor-related peptides and their receptors in human malignancies. Crit. Rev. Oncol. Hematol., 19, 183-232.
19. Shahbazi, M., Pravica, V., Nasreen, N., Fakhoury, H., Fryer, A.A., Strange, R.C., Hutchinson, P.E., Osborne, J.E., Lear, J.T., Smith, A.G. & Hutchinson, I.V. (2002) Association between functional polymorphism in EGF gene and malignant melanoma. Lancet, 359, 397-401.
20. Stoscheck, C.M. & King, L.E. (1986) Role of epidermal growth factor in carcinogenesis. Cancer Res., 46, 1030-1037.
21. Vauleon, E., Auger, N., Benouaich-Amiel, A., Laigle-Donadey, F., Kaloshi, G., Lejeune, J., Delattre, J.Y., Thillet, J. & Sanson, M. (2007) The 61 A/G EGF polymorphism is functional but is neither a prognostic marker nor a risk factor for glioblastoma. Cancer Genet. Cytogenet., 172, 33-37.
22. Wang, S., Zhao, Y., Ruan, Z., Chen, H., Fan, W., Chen, J., Wu, Q., Qian, J., Zhang, T., Huang, Y. & Lu, D. (2010) Association between EGF +61 G/A and glioma risk in a Chinese population. BMC Cancer, 10, 221.
23. Wrensch, M., Fisher, J.L., Schwartzbaum, J.A., Bondy, M., Berger, M. & Aldape, K.D. (2005) The molecular epidemiology of gliomas in adults. Neurosurg. Focus, 19, E5.
24. Wrensch, M., Minn, Y., Chew, T., Bondy, M. & Berger, M.S. (2002) Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol., 4, 278-299.
25. Xian, C.J., Li, L., Deng, Y.S., Zhao, S.P. & Zhou, X.F. (2001) Lack of effects of transforming growth factor-alpha gene knockout on peripheral nerve regeneration may result from compensatory mechanisms. Exp. Neurol., 172, 182-188.
26. Xu, W., Li, Y., Wang, X., Chen, B., Liu, S., Wang, Y., Zhao, W. & Wu, J. (2010) Association between EGF promoter polymorphisms and cancer risk: a meta-analysis. Med. Oncol., 27, 1389-1397.
27. Zhang, Y.M., Cao, C. & Liang, K. (2010) Genetic polymorphism of epidermal growth factor 61A>G and cancer risk: a meta-analysis. Cancer Epidemiol., 34, 150-156.
28. Zhu, Y. & Parada, L.F. (2002) The molecular and genetic basis of neurological tumours. Nat. Rev. Cancer, 2, 616-626.